e-learning
resources
Munich 2014
Monday, 08.09.2014
Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of diabetes mellitus on the Time of mycobacterial clearance from sputum during the treatment of multi-drugs resistant tuberculosis
P. Baghaei, P. Tabarsi, M. Marjani, A. Moniri, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
Source:
International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Session:
Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Session type:
Thematic Poster Session
Number:
2629
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Baghaei, P. Tabarsi, M. Marjani, A. Moniri, M. R. Masjedi (Tehran, Islamic Republic Of Iran). Effect of diabetes mellitus on the Time of mycobacterial clearance from sputum during the treatment of multi-drugs resistant tuberculosis. Eur Respir J 2014; 44: Suppl. 58, 2629
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Tuberculosis with diabetes mellitus: Does delayed sputum conversion always needs MDR evaluation?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Comparison of the clinical manifestations of tuberculosis in patients with different type’s of diabetes mellitus and without it
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Factors associated with severity of pulmonary tuberculosis and mortality in TB patients with diabetes mellitus
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Clinical manifestations and efficacy MDR/XDR tuberculosis in patients with different type’s of diabetes mellitus
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Plasma concentration of isoniazid and rifampin in new tuberculosis patients with and without diabetes mellitus
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Current status of fluoroquinolone use for treatment of tuberculosis in Korea
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
MOTT as a cause of treatment failure in pulmonary tuberculosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Impact of diabetes mellitus on drug-resistant tuberculosis treatment outcomes in Georgia – Cohort study
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015
Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013
Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Range of additional drug resistance of M.tuberculosis in XDR-TB patients
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept